{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:05:39Z","timestamp":1790665539649,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The prevalence of <jats:italic>Mycoplasma genitalium<\/jats:italic> (MG) and MG antimicrobial resistance (AMR) appear to be high internationally, however, prevalence data remain lacking globally. We evaluated the prevalence of MG and MG AMR-associated mutations in men who have sex with men (MSM) in Malta and Peru and women at-risk for sexually transmitted infections in Guatemala, South Africa, and Morocco; five countries in four WHO regions mostly lacking MG prevalence and AMR data, and estimated MG coinfections with <jats:italic>Chlamydia trachomatis<\/jats:italic> (CT), <jats:italic>Neisseria gonorrhoeae<\/jats:italic> (NG), and <jats:italic>Trichomonas vaginalis<\/jats:italic> (TV). Male urine and anorectal samples, and vaginal samples were tested for MG, CT, NG, and TV (only vaginal samples) using Aptima assays (Hologic). AMR-associated mutations in the MG 23S rRNA gene and <jats:italic>parC<\/jats:italic> gene were identified using ResistancePlus MG kit (SpeeDx) or Sanger sequencing. In total, 1,425 MSM and 1,398 women at-risk were recruited. MG was detected in 14.7% of MSM (10.0% in Malta and 20.0% Peru) and in 19.1% of women at-risk (12.4% in Guatemala, 16.0% Morocco, 22.1% South Africa). The prevalence of 23S rRNA and <jats:italic>parC<\/jats:italic> mutations among MSM was 68.1 and 29.0% (Malta), and 65.9 and 5.6% (Peru), respectively. Among women at-risk, 23S rRNA and <jats:italic>parC<\/jats:italic> mutations were revealed in 4.8 and 0% (Guatemala), 11.6 and 6.7% (Morocco), and 2.4 and 3.7% (South Africa), respectively. CT was the most frequent single coinfection with MG (in 2.6% of MSM and 4.5% of women at-risk), compared to NG\u2009+\u2009MG found in 1.3 and 1.0%, respectively, and TV\u2009+\u2009MG detected in 2.8% of women at-risk. In conclusion, MG is prevalent worldwide and enhanced aetiological MG diagnosis, linked to clinical routine detection of 23S rRNA mutations, in symptomatic patients should be implemented, where feasible. Surveillance of MG AMR and treatment outcome would be exceedingly valuable, nationally and internationally. High levels of AMR in MSM support avoiding screening for and treatment of MG in asymptomatic MSM and general population. Ultimately, novel therapeutic antimicrobials and\/or strategies, such as resistance-guided sequential therapy, and ideally an effective MG vaccine are essential.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1130762","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:44:30Z","timestamp":1677156270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Mycoplasma genitalium prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019\u20132021"],"prefix":"10.3389","volume":"14","author":[{"given":"Elena","family":"Shipitsyna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranmini","family":"Kularatne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silver K.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronza","family":"Hadad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeska","family":"Padovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Hancali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Oumzil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsy","family":"Camey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Blondeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Toskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/sextrans-2017-053384","article-title":"Prevalence of mycoplasma genitalium in different population groups: systematic review and meta-analysis","volume":"94","author":"Baumann","year":"2018","journal-title":"Sex. Transm. Infect."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e2127","DOI":"10.1093\/CID\/CIAA1832","article-title":"High prevalence and high rate of antibiotic resistance of mycoplasma genitalium infections in men who have sex with men: a substudy of the ANRS IPERGAY pre-exposure prophylaxis trial","volume":"73","author":"Ber\u00e7ot","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1071\/SH18221","article-title":"Prevalence of rectal mycoplasma genitalium and macrolide resistance in men who have sex with men attending Sydney sexual health Centre","volume":"17","author":"Bradley","year":"2020","journal-title":"Sex. Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/sextrans-2017-053480","article-title":"Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney","volume":"94","author":"Couldwell","year":"2018","journal-title":"Sex. Transm. Infect."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/sextrans-2020-054511","article-title":"An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018","volume":"97","author":"De Baetselier","year":"2021","journal-title":"Sex. Transm. Infect."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/09564624211070704","article-title":"Worryingly high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in mycoplasma genitalium among men who have sex with men with recurrent sexually transmitted infections","volume":"33","author":"De Baetselier","year":"2022","journal-title":"Int. J. STD AIDS"},{"key":"ref700","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/jac\/48.5.742","article-title":"Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment","volume":"48","author":"Deguchi","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/sextrans-2019-054386","article-title":"Macrolide and fluoroquinolone resistance of mycoplasma genitalium in southern Spain, 2018-2019","volume":"97","author":"De Salazar","year":"2021","journal-title":"Sex. Transm. Infect."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/J.JGAR.2019.06.015","article-title":"Prevalence of macrolide-and fluoroquinolone-resistant mycoplasma genitalium strains in clinical specimens from men who have sex with men of two sexually transmitted infection practices in Berlin, Germany","volume":"18","author":"Dumke","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0956462419890737","article-title":"Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review","volume":"31","author":"Fern\u00e1ndez-Huerta","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/apm.12792","article-title":"Macrolide and fluoroquinolone resistance in mycoplasma genitalium in two Swedish counties, 2011-2015","volume":"126","author":"Hadad","year":"2018","journal-title":"APMIS"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/OLQ.0000000000000246","article-title":"Prevalence and macrolide resistance of mycoplasma genitalium in south African women","volume":"42","author":"Hay","year":"2015","journal-title":"Sex. Transm. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e01084","DOI":"10.1128\/JCM.01084-20","article-title":"Prevalence of mycoplasma genitalium and antibiotic resistance-associated mutations in patients at a sexually transmitted infection Clinic in Iceland, and comparison of the S-DiaMGTV and Aptima mycoplasma genitalium assays for diagnosis","volume":"58","author":"Hilmarsd\u00f3ttir","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S396","DOI":"10.1093\/infdis\/jix145","article-title":"Mycoplasma genitalium infection in men","volume":"216","author":"Horner","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/S12879-020-4831-4","article-title":"STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany","volume":"20","author":"Jansen","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/QAD.0000000000003163","article-title":"Curable sexually transmitted infections among women with HIV in sub-Saharan Africa","volume":"36","author":"Jarolimova","year":"2022","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1086\/593188","article-title":"Azithromycin treatment failure in mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance","volume":"47","author":"Jensen","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of mycoplasma genitalium infections","volume":"36","author":"Jensen","year":"2022","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/OLQ.0000000000001647","article-title":"Etiological surveillance of male urethritis syndrome in South Africa: 2019 to 2020","volume":"49","author":"Kularatne","year":"","journal-title":"Sex. Transm. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/OLQ.0000000000001646","article-title":"Etiological surveillance of vaginal discharge syndrome in South Africa: 2019 to 2020","volume":"49","author":"Kularatne","year":"","journal-title":"Sex. Transm. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/sextrans-2019-054371","article-title":"Molecular epidemiological analysis of mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa","volume":"97","author":"Laumen","year":"2021","journal-title":"Sex. Transm. Infect."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JCM.01478-19","article-title":"Clinical evaluation of three commercial PCR assays for the detection of macrolide resistance in mycoplasma genitalium","volume":"58","author":"Le Roy","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in mycoplasma genitalium: a systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/OLQ.0000000000001631","article-title":"Molecular characterization and detection of macrolide and fluoroquinolone resistance determinants in mycoplasma genitalium in South Africa, 2015 to 2018","volume":"49","author":"Mahlangu","year":"2022","journal-title":"Sex. Transm. Dis."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/OLQ.0000000000001132","article-title":"Quinolone resistance-associated mutations in mycoplasma genitalium: not ready for prime time","volume":"47","author":"Manhart","year":"2020","journal-title":"Sex. Transm. Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/OLQ.0000000000001009","article-title":"Men who have sex with men with mycoplasma genitalium-positive nongonococcal urethritis are more likely to have macrolide-resistant strains than men with only female partners: a prospective study","volume":"46","author":"McIver","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12879-019-3797-6","article-title":"Macrolide and fluoroquinolone resistance-associated mutations in mycoplasma genitalium in Johannesburg, South Africa, 2007-2014","volume":"19","author":"Muller","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/infdis\/jiz550","article-title":"Moxifloxacin and sitafloxacin treatment failure in mycoplasma genitalium infection: association with parC mutation G248T (S83I) and concurrent gyrA mutations","volume":"221","author":"Murray","year":"","journal-title":"J. Infect. Dis."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1099\/jmm.0.001140","article-title":"Performance of the ResistancePlus MG diagnostic test for mycoplasma genitalium using samples collected with Hologic Aptima specimen collection kits","volume":"69","author":"Murray","year":"","journal-title":"J. Med. Microbiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/CID\/CIZ045","article-title":"Prevalence and antimicrobial resistance of mycoplasma genitalium infection among women living with human immunodeficiency virus in South Africa: a prospective cohort study","volume":"69","author":"Ong","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/J.ECLINM.2021.100779","article-title":"Impact of screening on the prevalence and incidence of mycoplasma genitalium and its macrolide resistance in men who have sex with men living in Australia: a mathematical model","volume":"33","author":"Ong","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3201\/EID2504.181258","article-title":"Symptoms, sites, and significance of mycoplasma genitalium in men who have sex with men","volume":"25","author":"Read","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e0236921","DOI":"10.1128\/JCM.02369-21","article-title":"Clinical importance of superior sensitivity of the Aptima TMA-based assays for mycoplasma genitalium detection","volume":"60","author":"Salado-Rasmussen","year":"2022","journal-title":"J. Clin. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance","volume":"36","author":"Shimada","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0175763","DOI":"10.1371\/journal.pone.0175763","article-title":"Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in mycoplasma genitalium in five cities in Russia and Estonia","volume":"12","author":"Shipitsyna","year":"2017","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/14737159.2020.1842198","article-title":"A profile of the FDA-approved and CE\/IVD-marked Aptima mycoplasma genitalium assay (Hologic) and key priorities in the management of M. genitalium infections","volume":"20","author":"Shipitsyna","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2100591","DOI":"10.2807\/1560-7917.es.2022.27.14.2100591","article-title":"HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019","volume":"27","author":"Streeck","year":"2022","journal-title":"Euro Surveill."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S1473-3099(22)00446-7","article-title":"Can ParC Ser83Ile status predict fluoroquinolone efficacy in mycoplasma genitalium infection? - Authors' reply","volume":"22","author":"Sweeney","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1128\/JCM.02312-16","article-title":"Prospective evaluation of ResistancePlus MG, a new multiplex quantitative PCR assay for detection of mycoplasma genitalium and macrolide resistance","volume":"55","author":"Tabrizi","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: Gonorrhoea and mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"The Lancet Microbe"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cmi.2017.09.006","article-title":"Clinical and analytical evaluation of the new Aptima mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016","volume":"24","author":"Unemo","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/sextrans-2019-054335","article-title":"Mycoplasma genitalium acquisition and macrolide resistance after initiation of HIV pre-exposure prophylaxis in men who have sex with men","volume":"96","author":"Van Praet","year":"2020","journal-title":"Sex. Transm. Infect."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/jia2.25343","article-title":"Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward","volume":"22","author":"Wi","year":"2019","journal-title":"J. Int. AIDS Soc."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1130762\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T12:44:33Z","timestamp":1677156273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1130762\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":46,"alternative-id":["10.3389\/fmicb.2023.1130762"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1130762","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"article-number":"1130762"}}